Who
Beth J. Hoffman
Director
Company insider
Files Form 4 as: Director, Biofrontera.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 18 May 2022
- Last trade
- 4 Mar 2026
- Last filed
- 6 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 6 Mar 2026 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 22 Jul 2025filed 16 Sep 2025 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 12 Jul 2024filed 16 Jul 2024 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 18 May 2022filed 6 Jun 2022 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 18 May 2022filed 26 May 2022 | BFRI Biofronteraoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.